{"id":"NCT00300274","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection","officialTitle":"A 24-month, Multi-center, Randomized, Open-label, Non-inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-controlled Everolimus With Reduced Cyclosporine Versus 3.0 g Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Heart Transplant Recipients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2006-03-08","resultsPosted":"2012-08-16","lastUpdate":"2012-08-16"},"enrollment":721,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Graft Rejection"],"interventions":[{"type":"DRUG","name":"everolimus","otherNames":["Zortress速","Certican速"]},{"type":"DRUG","name":"mycophenolate mofetil","otherNames":["Cellcept速"]},{"type":"DRUG","name":"cyclosporine","otherNames":["Neoral速"]},{"type":"DRUG","name":"corticosteroids","otherNames":[]}],"arms":[{"label":"everolimus 1.5 mg","type":"EXPERIMENTAL"},{"label":"everolimus 3.0 mg","type":"EXPERIMENTAL"},{"label":"mycophenolate mofetil","type":"ACTIVE_COMPARATOR"}],"summary":"This trial was to examine the impact of everolimus and reduced dose of cyclosporine on efficacy and safety compared to mycophenolate mofetil and a standard dose of cyclosporine in heart transplant recipients.","primaryOutcome":{"measure":"Percentage of Participants With Composite Efficacy Failure at 12 Months","timeFrame":"12 Months","effectByArm":[{"arm":"Everolimus 1.5 mg","deltaMin":35.1,"sd":null},{"arm":"Everolimus 3.0 mg","deltaMin":35.1,"sd":null},{"arm":"Mycophenolate Mofetil","deltaMin":33.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":64,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","France","Germany","Italy","New Zealand","Norway","Puerto Rico","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":209,"n":279},"commonTop":["Hypertension","Oedema peripheral","Anaemia","Pericardial effusion","Headache"]}}